A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip
NCT00131326
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Osteoarthritis, Hip
Musculoskeletal Diseases
Interventions
DEVICE:
Synvisc (hylan G-F 20)
Sponsor
Genzyme, a Sanofi Company